{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:20:27Z","timestamp":1791908427253,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T00:00:00Z","timestamp":1687564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hellenic Journal of Cardiology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.hjc.2023.06.005","type":"journal-article","created":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T21:11:04Z","timestamp":1688505064000},"page":"65-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Risk of arterial thromboembolism, bleeding and mortality in atrial fibrillation patients with comorbid cancer: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3736-9103","authenticated-orcid":false,"given":"Charalampos","family":"Balomenakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4981-8121","authenticated-orcid":false,"given":"Andreas S.","family":"Papazoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9537-9591","authenticated-orcid":false,"given":"Dimitra","family":"Vlachopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1170-9133","authenticated-orcid":false,"given":"Anastasios","family":"Kartas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios V.","family":"Moysidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Vouloagkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Tsagkaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Georgopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Samaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstratios","family":"Karagiannidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7491-6319","authenticated-orcid":false,"given":"George","family":"Giannakoulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.hjc.2023.06.005_bib1","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: the Framingham Heart Study","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.hjc.2023.06.005_bib2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.hjc.2023.06.005_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccep.2020.10.010","article-title":"Epidemiology of atrial fibrillation: Geographic\/Ecological risk factors, age, sex, genetics","volume":"13","author":"Zhang","year":"2021","journal-title":"Card Electrophysiol Clin"},{"key":"10.1016\/j.hjc.2023.06.005_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.hjc.2023.04.008","article-title":"The burden of atrial fibrillation and heart failure in hospitalized patients. A real-world survey in a nationwide snapshot","author":"Iliodromitis","year":"2023","journal-title":"Hellenic Journal of Cardiology [Internet]"},{"key":"10.1016\/j.hjc.2023.06.005_bib5","unstructured":"(CDC) CfDCaP. Leading Causes of Death|cdc.gov [Internet]. [updated March 1,2021. Available from: https:\/\/www.cdc.gov\/nchs\/fastats\/leading-causes-of-death.htm."},{"issue":"10","key":"10.1016\/j.hjc.2023.06.005_bib6","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jacc.2013.11.026","article-title":"Insights into onco-cardiology: Atrial fibrillation in cancer","volume":"63","author":"Farmakis","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.hjc.2023.06.005_bib7","first-page":"233","article-title":"Atrial fibrillation and cancer","volume":"3","author":"Siontis Konstantinos","year":"2021","journal-title":"JACC (J Am Coll Cardiol): CardioOncology."},{"issue":"2","key":"10.1016\/j.hjc.2023.06.005_bib8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jaccao.2021.03.006","article-title":"Risk of atrial fibrillation according to cancer type: A nationwide population-based study","volume":"3","author":"Yun","year":"2021","journal-title":"JACC CardioOncol"},{"issue":"17","key":"10.1016\/j.hjc.2023.06.005_bib9","article-title":"Atrial fibrillation and risk of cancer: A Danish population-based cohort study","volume":"7","author":"Vinter","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"8","key":"10.1016\/j.hjc.2023.06.005_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102861","article-title":"Atrial fibrillation as a marker of occult cancer","volume":"9","author":"Ostenfeld","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.hjc.2023.06.005_bib11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ana.24325","article-title":"Association between incident cancer and subsequent stroke","volume":"77","author":"Navi","year":"2015","journal-title":"Ann Neurol"},{"issue":"Suppl 2","key":"10.1016\/j.hjc.2023.06.005_bib12","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/S0049-3848(14)50009-6","article-title":"Bleeding complications during anticoagulant treatment in patients with cancer","volume":"133","author":"Kamphuisen","year":"2014","journal-title":"Thromb Res"},{"issue":"7","key":"10.1016\/j.hjc.2023.06.005_bib13","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ajh.25494","article-title":"Bleeding incidence and risk factors among cancer patients treated with anticoagulation","volume":"94","author":"Angelini","year":"2019","journal-title":"Am J Hematol"},{"issue":"12","key":"10.1016\/j.hjc.2023.06.005_bib14","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1200\/JOP.18.00592","article-title":"Atrial fibrillation and stroke risk in patients with cancer: A primer for oncologists","volume":"15","author":"Sorigue","year":"2019","journal-title":"J\u00a0Oncol Pract"},{"issue":"2","key":"10.1016\/j.hjc.2023.06.005_bib15","first-page":"37","article-title":"Towards a beating cardiovascular disease plan for Europe","volume":"27","author":"European Observatory on Health","year":"2022","journal-title":"Eurohealth"},{"key":"10.1016\/j.hjc.2023.06.005_bib16","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.hjc.2023.06.005_bib17","unstructured":"The Clarity Review Group MU. Tool to Assess Risk of Bias in Cohort Studies Online [Available from: http:\/\/help.magicapp.org\/knowledgebase\/articles\/327941-tool-to-assess-risk-of-bias-in-cohort-studies."},{"issue":"3","key":"10.1016\/j.hjc.2023.06.005_bib18","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/biom.12817","article-title":"Quantifying publication bias in meta-analysis","volume":"74","author":"Lin","year":"2018","journal-title":"Biometrics"},{"issue":"5","key":"10.1016\/j.hjc.2023.06.005_bib19","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/sim.2971","article-title":"Arcsine test for publication bias in meta-analyses with binary outcomes","volume":"27","author":"R\u00fccker","year":"2008","journal-title":"Stat Med"},{"issue":"4","key":"10.1016\/j.hjc.2023.06.005_bib20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"7","key":"10.1016\/j.hjc.2023.06.005_bib21","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.004580","article-title":"Importance of considering competing risks in time-to-event analyses: Application to stroke risk in a retrospective cohort study of elderly patients with atrial fibrillation","volume":"11","author":"Abdel-Qadir","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"2","key":"10.1016\/j.hjc.2023.06.005_bib22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/ehjqcco\/qcy040","article-title":"Efficacy and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and a history of cancer: observations from ROCKET AF","volume":"5","author":"Chen","year":"2019","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"6","key":"10.1016\/j.hjc.2023.06.005_bib23","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1177\/2047487318759858","article-title":"CHA(2)DS(2)-VASc score and risk of thromboembolism and bleeding in patients with atrial fibrillation and recent cancer","volume":"25","author":"D'Souza","year":"2018","journal-title":"Eur J Prev Cardiol"},{"issue":"2","key":"10.1016\/j.hjc.2023.06.005_bib24","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.thromres.2015.06.011","article-title":"Cancer as a risk factor for stroke in atrial fibrillation patients receiving long-term oral anticoagulant therapy","volume":"136","author":"Denas","year":"2015","journal-title":"Thromb Res"},{"issue":"16","key":"10.1016\/j.hjc.2023.06.005_bib25","article-title":"Efficacy and safety of edoxaban in patients with active malignancy and atrial fibrillation: Analysis of the ENGAGE AF - TIMI 48 Trial","volume":"7","author":"Fanola","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.hjc.2023.06.005_bib26","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.amjcard.2018.11.046","article-title":"Bleeding and new-onset cancers in patients with atrial fibrillation receiving Nonvitamin k antagonist oral anticoagulants","volume":"123","author":"Hu","year":"2019","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.hjc.2023.06.005_bib27","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1253\/circj.CJ-21-0631","article-title":"Effect of cancer on clinical outcomes in elderly patients with non-valvular atrial fibrillation - Substudy of the ANAFIE registry","volume":"86","author":"Ikeda","year":"2022","journal-title":"Circ J"},{"issue":"12","key":"10.1016\/j.hjc.2023.06.005_bib28","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.jfma.2020.02.003","article-title":"Factors for recurrent stroke among Asian patients with non-valvular atrial fibrillation under non-vitamin K antagonist oral anticoagulant therapy","volume":"119","author":"Lin","year":"2020","journal-title":"J\u00a0Formos Med Assoc"},{"issue":"7","key":"10.1016\/j.hjc.2023.06.005_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13773","article-title":"Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EURObservational research programme in atrial fibrillation general long-term registry","volume":"52","author":"Malavasi","year":"2022","journal-title":"Eur J Clin Invest"},{"issue":"12","key":"10.1016\/j.hjc.2023.06.005_bib30","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.amjmed.2017.06.026","article-title":"Efficacy and safety of apixaban versus warfarin in patients with atrial fibrillation and a history of cancer: Insights from the ARISTOTLE trial","volume":"130","author":"Melloni","year":"2017","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.hjc.2023.06.005_bib31","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/ehjqcco\/qcx004","article-title":"Management and outcomes of patients with atrial fibrillation and a history of cancer: the ORBIT-AF registry","volume":"3","author":"Melloni","year":"2017","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.hjc.2023.06.005_bib32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.breast.2019.05.017","article-title":"Current status of anticoagulation in patients with breast cancer and atrial fibrillation","volume":"46","author":"Pardo Sanz","year":"2019","journal-title":"Breast"},{"issue":"12","key":"10.1016\/j.hjc.2023.06.005_bib33","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/cncr.33470","article-title":"Thromboembolism, mortality, and bleeding in 2,435,541 atrial fibrillation patients with and without cancer: A nationwide cohort study","volume":"127","author":"Pastori","year":"2021","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.hjc.2023.06.005_bib34","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1002\/ijc.33179","article-title":"Cancer-specific ischemic complications in elderly patients with atrial fibrillation: Data from the prospective ATHERO-AF study","volume":"147","author":"Pastori","year":"2020","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.hjc.2023.06.005_bib35","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.4022\/jafib.2105","article-title":"The impact of cancer on major bleeding and stroke\/systemic emboli in patients using direct oral anticoagulants: From the database of a single-center registry","volume":"11","author":"Sato","year":"2018","journal-title":"J\u00a0Atr Fibrillation"},{"key":"10.1016\/j.hjc.2023.06.005_bib36","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijcard.2018.07.138","article-title":"Patients with cancer and atrial fibrillation treated with doacs: A prospective cohort study","volume":"269","author":"Vedovati","year":"2018","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.hjc.2023.06.005_bib37","first-page":"e176","article-title":"Atrial fibrillation, oral anticoagulants, and concomitant active cancer: Benefits and risks","volume":"5","author":"Atterman","year":"2021","journal-title":"The Open"},{"issue":"11","key":"10.1016\/j.hjc.2023.06.005_bib38","first-page":"1449","article-title":"Perioperative atrial fibrillation in noncardiac surgeries for malignancies and one-year recurrence","volume":"35","author":"Higuchi","year":"2019","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.hjc.2023.06.005_bib39","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/394740","article-title":"Arterial and venous thrombosis in cancer patients","volume":"2011","author":"Blann","year":"2011","journal-title":"Cardiol Res Pract"},{"key":"10.1016\/j.hjc.2023.06.005_bib40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.thromres.2016.01.006","article-title":"Role of platelets in cancer and cancer-associated thrombosis: Experimental and clinical evidences","volume":"139","author":"Mezouar","year":"2016","journal-title":"Thromb Res"},{"issue":"5","key":"10.1016\/j.hjc.2023.06.005_bib41","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11936-018-0635-x","article-title":"Arterial thrombosis in patients with cancer","volume":"20","author":"Tuzovic","year":"2018","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"3","key":"10.1016\/j.hjc.2023.06.005_bib42","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/j.ijcard.2013.03.010","article-title":"Systemic VEGF inhibition accelerates experimental atherosclerosis and disrupts endothelial homeostasis--implications for cardiovascular safety","volume":"168","author":"Winnik","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hjc.2023.06.005_bib43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.thromres.2019.10.004","article-title":"Frequency of arterial thromboembolism in populations with malignancies: A systematic review","volume":"184","author":"Yu","year":"2019","journal-title":"Thromb Res"},{"issue":"2","key":"10.1016\/j.hjc.2023.06.005_bib44","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1055\/s-0039-3400300","article-title":"Efficacy and safety of Nonvitamin K oral anticoagulants in patients with atrial fibrillation and cancer: A study-level meta-analysis","volume":"120","author":"Cavallari","year":"2020","journal-title":"Thromb Haemostasis"},{"issue":"14","key":"10.1016\/j.hjc.2023.06.005_bib45","article-title":"Non vitamin K antagonist oral anticoagulants versus warfarin in patients with cancer and atrial fibrillation: A systematic review and meta-analysis","volume":"8","author":"Deng","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.hjc.2023.06.005_bib46","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.amjcard.2017.11.027","article-title":"In-hospital cerebrovascular outcomes of patients with atrial fibrillation and cancer (from the national inpatient sample database)","volume":"121","author":"Elbadawi","year":"2018","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.hjc.2023.06.005_bib47","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.amjcard.2018.02.060","article-title":"Risk of cardioembolic stroke in patients with cancer and atrial fibrillation","volume":"121","author":"Sorigue","year":"2018","journal-title":"Am J Cardiol"},{"issue":"16","key":"10.1016\/j.hjc.2023.06.005_bib48","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2018.07.077","article-title":"Provider specialty, anticoagulation, and stroke risk in patients with atrial fibrillation and cancer","volume":"72","author":"O'Neal","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"41","key":"10.1016\/j.hjc.2023.06.005_bib49","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.hjc.2023.06.005_bib50","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/j.amjcard.2017.08.038","article-title":"Usefulness of CHADS2 and CHA2DS2-VASc scores for stroke prediction in patients with cancer and atrial fibrillation","volume":"120","author":"Patell","year":"2017","journal-title":"Am J Cardiol"},{"issue":"08","key":"10.1016\/j.hjc.2023.06.005_bib51","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1055\/s-0041-1729885","article-title":"The growing impact of cardiovascular oncology: Epidemiology and pathophysiology","volume":"47","author":"Tufano","year":"2021","journal-title":"Semin Thromb Hemost"}],"container-title":["Hellenic Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1109966623001100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1109966623001100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:16:58Z","timestamp":1761099418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1109966623001100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":51,"alternative-id":["S1109966623001100"],"URL":"https:\/\/doi.org\/10.1016\/j.hjc.2023.06.005","relation":{},"ISSN":["1109-9666"],"issn-type":[{"value":"1109-9666","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of arterial thromboembolism, bleeding and mortality in atrial fibrillation patients with comorbid cancer: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Hellenic Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hjc.2023.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Hellenic Society of Cardiology. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}